Skip to main content

Never miss an update!

Subscribe to receive weekly updates:

You have successfully subscribed. Something went wrong, please try again later
ProteoGenix
ProteoGenix
  • Herstellung von monoklonalen antikörpern

    Philippe Funfrock Philippe Funfrock August 13, 2018 6 min read

    [get_contact_slide form=”1279″ title=”Form. Antikörperherstellung”] [get_breadcrumbs class=”banner_breadcumb”] ProteoGenix hat XtenCHO entwickelt, das produktivste Expressionssystem zur Herstellung von transienten monoklonalen Antikörpern, das sogar die Leistung von ExpiCHO übertrifft. Aufbauend…

    Read more
  1. From the first to the fifth generation of CAR-T cells

    Read more
  2. The structure of CAR-T cells

    Read more
  3. Robust methods for the detailed analysis of drug-to-antibody ratio (DAR) and drug load distribution

    Read more
  4. ADC linkers: Definition and examples

    Read more
  5. How to choose the best linker for an ADC? Cleavable vs. non-cleavable

    Read more
ProteoGenix
Categories
  • Antibody production
  • Protein production
  • Peptide synthesis
  • Success stories
  • Unkategorisiert
About Us

©  ProteBlog 2025